Fresenius SE & Co. KGaA

FRE.DEHealthcare

Sentinellis Health Score

4.7/10

Moderate concerns

Market Cap

EUR 22.3B

Revenue

EUR 22.9B

P/E Ratio

14.8x

AI Summary

Fresenius runs two main businesses: Fresenius Kabi makes biopharmaceuticals, IV drugs, clinical nutrition products, and medical devices for critically and chronically ill patients, while Fresenius Helios operates hospitals, medical care centers, and outpatient facilities across multiple continents [Yahoo Finance]. The company also develops biosimilar drugs and medical technologies including infusion pumps and apheresis machines [Yahoo Finance].

Fresenius SE & Co. KGaA is a German healthcare company operating hospitals (Fresenius Helios) and producing critical-care pharmaceuticals and medical devices (Fresenius Kabi) across North America, Europe, Asia-Pacific, Latin America, and Africa [Yahoo Finance]. The company employs 177,783 people and generated EUR 22.9 billion in revenue with modest growth of +4.8% year-over-year [Yahoo Finance]. Its subsidiary Fresenius Medical Care recently reported earnings that were stronger than headlines suggested, with EUR 216 million in one-time costs masking underlying profitability [Yahoo Finance].

Fresenius shows moderate financial health with steady cash generation but elevated debt levels that limit flexibility.

Confidence6/10